Targeted reinnervation
Targeted reinnervation is a surgical procedure that aims to improve the control of prosthetic devices by amputees. This technique was developed by Dr. Todd Kuiken and his team at the Rehabilitation Institute of Chicago (RIC).
Overview[edit | edit source]
Targeted reinnervation involves the transfer of residual nerves, which previously controlled the muscles of the amputated limb, to new muscle sites. These nerves grow into the transferred muscles and provide a means for the amputee to control their prosthetic device. The procedure is most commonly performed on upper limb amputees, but can also be used for lower limb amputees.
Procedure[edit | edit source]
The procedure begins with the identification of the residual nerves in the amputated limb. These nerves are then surgically transferred to nearby muscles that are no longer biomechanically functional due to the amputation. Over time, the transferred nerves grow into the new muscle, providing a new means of controlling the prosthetic device.
Benefits[edit | edit source]
Targeted reinnervation has several benefits. It provides amputees with improved control of their prosthetic devices, which can lead to increased functionality and independence. Additionally, it can potentially reduce the occurrence of phantom limb pain, a common issue among amputees.
Risks and Complications[edit | edit source]
As with any surgical procedure, targeted reinnervation carries some risks. These can include infection, nerve damage, and the potential for the procedure to be unsuccessful. However, the benefits often outweigh the risks for many amputees.
Future Developments[edit | edit source]
Research is ongoing to further improve the targeted reinnervation procedure and the prosthetic devices used in conjunction with it. This includes the development of more sophisticated prosthetic devices that can provide sensory feedback, further improving the functionality and realism of the prosthetic limb.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
